A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Clinical trial NCT04187300 · COMPLETED
Trial details
- NCT number
- NCT04187300
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2020-09-23
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.